In the news: AI firm develops biomarkers for patients with chronic bowel conditions

AI start-up Nori Health is developing digital biomarkers, specifically linked to patients with chronic bowel conditions like Crohn’s disease and ulcerative colitis.

These biomarkers suggest connections between behavior and disease activity, including symptoms and inflammation.

Several digital biomarkers have been identified by Nori Health in behavioral data regarding exercising, nutrition, stress reduction methods, mental health and many more.

Read the full article on Medtech Innovation >